293 related articles for article (PubMed ID: 21927811)
1. Exploring the intricate regulatory network controlling the thiazide-sensitive NaCl cotransporter (NCC).
Dimke H
Pflugers Arch; 2011 Dec; 462(6):767-77. PubMed ID: 21927811
[TBL] [Abstract][Full Text] [Related]
2. Phosphatidylinositol 3-kinase/Akt signaling pathway activates the WNK-OSR1/SPAK-NCC phosphorylation cascade in hyperinsulinemic db/db mice.
Nishida H; Sohara E; Nomura N; Chiga M; Alessi DR; Rai T; Sasaki S; Uchida S
Hypertension; 2012 Oct; 60(4):981-90. PubMed ID: 22949526
[TBL] [Abstract][Full Text] [Related]
3. Dysregulation of the WNK4-SPAK/OSR1 pathway has a minor effect on baseline NKCC2 phosphorylation.
Maeoka Y; Nguyen LT; Sharma A; Cornelius RJ; Su XT; Gutierrez MR; Carbajal-Contreras H; Castañeda-Bueno M; Gamba G; McCormick JA
Am J Physiol Renal Physiol; 2024 Jan; 326(1):F39-F56. PubMed ID: 37881876
[TBL] [Abstract][Full Text] [Related]
4. WNK kinases regulate thiazide-sensitive Na-Cl cotransport.
Yang CL; Angell J; Mitchell R; Ellison DH
J Clin Invest; 2003 Apr; 111(7):1039-45. PubMed ID: 12671053
[TBL] [Abstract][Full Text] [Related]
5. SPAK isoforms and OSR1 regulate sodium-chloride co-transporters in a nephron-specific manner.
Grimm PR; Taneja TK; Liu J; Coleman R; Chen YY; Delpire E; Wade JB; Welling PA
J Biol Chem; 2012 Nov; 287(45):37673-90. PubMed ID: 22977235
[TBL] [Abstract][Full Text] [Related]
6. SPAK deficiency corrects pseudohypoaldosteronism II caused by WNK4 mutation.
Chu PY; Cheng CJ; Wu YC; Fang YW; Chau T; Uchida S; Sasaki S; Yang SS; Lin SH
PLoS One; 2013; 8(9):e72969. PubMed ID: 24039833
[TBL] [Abstract][Full Text] [Related]
7. Roles of WNK4 and SPAK in K
Mukherjee A; Yang CL; McCormick JA; Martz K; Sharma A; Ellison DH
Am J Physiol Renal Physiol; 2021 May; 320(5):F719-F733. PubMed ID: 33719576
[TBL] [Abstract][Full Text] [Related]
8. Aldosterone mediates activation of the thiazide-sensitive Na-Cl cotransporter through an SGK1 and WNK4 signaling pathway.
Rozansky DJ; Cornwall T; Subramanya AR; Rogers S; Yang YF; David LL; Zhu X; Yang CL; Ellison DH
J Clin Invest; 2009 Sep; 119(9):2601-12. PubMed ID: 19690383
[TBL] [Abstract][Full Text] [Related]
9. WNK bodies cluster WNK4 and SPAK/OSR1 to promote NCC activation in hypokalemia.
Thomson MN; Cuevas CA; Bewarder TM; Dittmayer C; Miller LN; Si J; Cornelius RJ; Su XT; Yang CL; McCormick JA; Hadchouel J; Ellison DH; Bachmann S; Mutig K
Am J Physiol Renal Physiol; 2020 Jan; 318(1):F216-F228. PubMed ID: 31736353
[TBL] [Abstract][Full Text] [Related]
10. WNK4 inhibits NCC protein expression through MAPK ERK1/2 signaling pathway.
Zhou B; Wang D; Feng X; Zhang Y; Wang Y; Zhuang J; Zhang X; Chen G; Delpire E; Gu D; Cai H
Am J Physiol Renal Physiol; 2012 Mar; 302(5):F533-9. PubMed ID: 22114204
[TBL] [Abstract][Full Text] [Related]
11. Targeted disruption of the Wnk4 gene decreases phosphorylation of Na-Cl cotransporter, increases Na excretion and lowers blood pressure.
Ohta A; Rai T; Yui N; Chiga M; Yang SS; Lin SH; Sohara E; Sasaki S; Uchida S
Hum Mol Genet; 2009 Oct; 18(20):3978-86. PubMed ID: 19633012
[TBL] [Abstract][Full Text] [Related]
12. WNK4 is indispensable for the pathogenesis of pseudohypoaldosteronism type II caused by mutant KLHL3.
Susa K; Sohara E; Takahashi D; Okado T; Rai T; Uchida S
Biochem Biophys Res Commun; 2017 Sep; 491(3):727-732. PubMed ID: 28743496
[TBL] [Abstract][Full Text] [Related]
13. Phenotypes of pseudohypoaldosteronism type II caused by the WNK4 D561A missense mutation are dependent on the WNK-OSR1/SPAK kinase cascade.
Chiga M; Rafiqi FH; Alessi DR; Sohara E; Ohta A; Rai T; Sasaki S; Uchida S
J Cell Sci; 2011 May; 124(Pt 9):1391-5. PubMed ID: 21486947
[TBL] [Abstract][Full Text] [Related]
14. Dietary potassium stimulates Ppp1Ca-Ppp1r1a dephosphorylation of kidney NaCl cotransporter and reduces blood pressure.
Grimm PR; Tatomir A; Rosenbaek LL; Kim BY; Li D; Delpire EJ; Fenton RA; Welling PA
J Clin Invest; 2023 Nov; 133(21):. PubMed ID: 37676724
[TBL] [Abstract][Full Text] [Related]
15. Impaired phosphorylation of Na(+)-K(+)-2Cl(-) cotransporter by oxidative stress-responsive kinase-1 deficiency manifests hypotension and Bartter-like syndrome.
Lin SH; Yu IS; Jiang ST; Lin SW; Chu P; Chen A; Sytwu HK; Sohara E; Uchida S; Sasaki S; Yang SS
Proc Natl Acad Sci U S A; 2011 Oct; 108(42):17538-43. PubMed ID: 21972418
[TBL] [Abstract][Full Text] [Related]
16. The thiazide-sensitive Na-Cl cotransporter is regulated by a WNK kinase signaling complex.
Yang CL; Zhu X; Ellison DH
J Clin Invest; 2007 Nov; 117(11):3403-11. PubMed ID: 17975670
[TBL] [Abstract][Full Text] [Related]
17. WNK-SPAK/OSR1-NCC kinase signaling pathway as a novel target for the treatment of salt-sensitive hypertension.
Brown A; Meor Azlan NF; Wu Z; Zhang J
Acta Pharmacol Sin; 2021 Apr; 42(4):508-517. PubMed ID: 32724175
[TBL] [Abstract][Full Text] [Related]
18. Arginine vasopressin regulates the renal Na
Carbajal-Contreras H; Murillo-de-Ozores AR; Magaña-Avila G; Marquez-Salinas A; Bourqui L; Tellez-Sutterlin M; Bahena-Lopez JP; Cortes-Arroyo E; Behn-Eschenburg SG; Lopez-Saavedra A; Vazquez N; Ellison DH; Loffing J; Gamba G; Castañeda-Bueno M
Am J Physiol Renal Physiol; 2024 Feb; 326(2):F285-F299. PubMed ID: 38096266
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation regulates NCC stability and transporter activity in vivo.
Yang SS; Fang YW; Tseng MH; Chu PY; Yu IS; Wu HC; Lin SW; Chau T; Uchida S; Sasaki S; Lin YF; Sytwu HK; Lin SH
J Am Soc Nephrol; 2013 Oct; 24(10):1587-97. PubMed ID: 23833262
[TBL] [Abstract][Full Text] [Related]
20. γ-Adducin stimulates the thiazide-sensitive NaCl cotransporter.
Dimke H; San-Cristobal P; de Graaf M; Lenders JW; Deinum J; Hoenderop JG; Bindels RJ
J Am Soc Nephrol; 2011 Mar; 22(3):508-17. PubMed ID: 21164023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
